Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
360
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine

Maria TsirogianniDepartment of Hematology and Bone Marrow Transplantation, Saint Savvas Regional Cancer Hospital, Athens, Greece; View further author information
,
Eirini GrigoriouDepartment of Immunology and Histocompatibility, “Evangelismos” General Hospital, Athens, Greece;View further author information
,
Violetta KapsimalliDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Kleopatra DaglaHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Maria StamouliHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Konstantinos GkirkasHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Eve KonstaHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Angeliki KaragiannidouHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Konstantinos GkodopoulosHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Georgia StavroulakiHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Vassiliki PappaHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;View further author information
,
Maria AngelopoulouDepartment of Hematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece; View further author information
,
Mark LowdellInstitute of Immunity and Transplantation Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital, London, UKView further author information
&
Panagiotis TsirigotisHematology Division, 2nd Department of Internal Medicine, “ATTIKO” General University Hospital, National and Kapodistrian University of Athens, Athens, Greece;Correspondence[email protected]
View further author information
 show all
Pages 2457-2463 | Received 03 Dec 2018, Accepted 03 Feb 2019, Published online: 05 Apr 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lirong Nie, Yuming Zhang, Yuchan You, Changmei Lin, Qinghua Li, Wenbo Deng, Jingzhi Ma, Wenying Luo & Honghua He. (2022) The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients. Hematology 27:1, pages 833-841.
Read now
Sameem M. Abedin & Leonidas C. Platanias. (2019) Natural killer cell activity and survival after azacitidine treatment in high-risk MDS. Leukemia & Lymphoma 60:10, pages 2343-2344.
Read now
Li Li, Ran Zhang, Weijie Cao, Zhilei Bian, Yang Qin, Rong Guo, Suping Zhang, Yingnan Peng, Dingming Wan & Wang Ma. Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Leukemia & Lymphoma 0:0, pages 1-10.
Read now

Articles from other publishers (7)

Shunjie Wu, Haizhen Li, Xianchao Wang, Tuanyun Ji, Xiaojun Xu & Qiaohong Yang. (2023) Effects of different allo-Treg/allo-NK ratios on graft-versus-host disease in transplanted mice. Transplant Immunology 80, pages 101893.
Crossref
Andrew Kent, Lyndsey S. Crump & Eduardo Davila. (2023) Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. Frontiers in Immunology 14.
Crossref
Helena Arellano-Ballestero, May Sabry & Mark W. Lowdell. (2023) A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome. Cells 12:4, pages 633.
Crossref
Yannick Simoni & Nicolas Chapuis. (2022) Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications. Diagnostics 12:7, pages 1659.
Crossref
Jeffrey J. Bednarski, Clare Zimmerman, Melissa M. Berrien-Elliott, Jennifer A. Foltz, Michelle Becker-HapakCarly C. NealMark FosterTimothy SchappeEthan McClainPatrick P. Pence, Sweta Desai, Samantha Kersting-SchadekPamela Wong, David A. Russler-Germain, Bryan Fisk, Wen-Rong Lie, Jeremy EiseleStephanie Hyde, Sima T. Bhatt, Obi L. Griffith, Malachi GriffithAllegra A. Petti, Amanda F. CashenTodd A. Fehniger. (2022) Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant. Blood 139:11, pages 1670-1683.
Crossref
Mattias Carlsten & Marcus Järås. (2019) Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells. Frontiers in Immunology 10.
Crossref
Gonzalez-Rodriguez, Villa-Álvarez, Sordo-Bahamonde, Lorenzo-Herrero & Gonzalez. (2019) NK Cells in the Treatment of Hematological Malignancies. Journal of Clinical Medicine 8:10, pages 1557.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.